Axsome Advances Sleep Disorder Pipeline as Sunosi Prescriptions ...
1 day ago · Axsome Therapeutics reported continued growth in its sleep medicine portfolio for the third quarter of 2024, driven by increased uptake of its wake-promoting drug Sunosi and …
OFF
Axsome Therapeutics Reports Third Quarter 2024 ... - Markets Insider
2 weeks from now
2 days ago · Sunosi. Approximately 47,000 prescriptions were written for Sunosi in the U.S. in the third quarter of 2024, representing an increase of 15% compared to the same period in 2023, …
businessinsider.com
OFF
Axsome (AXSM) Banks On Auvelity & Sunosi To Fuel Growth
2 weeks from now
Aug 15, 2024 · The acquisition of Sunosi from Jazz diversified Axsome’s portfolio to two marketed drugs. In the first half of 2024, Sunosi’s net product sales were $42.2 million, reflecting an …
nasdaq.com
OFF
Axsome Therapeutics Q3 Earnings: Stay For Near Term Catalysts, …
2 weeks from now
2 days ago · Summary. Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m, up 81% YoY, but net loss increased to $(64.6m). Despite positive market …
seekingalpha.com
OFF
Axsome Therapeutics Reports Third Quarter 2024 Financial Results …
2 weeks from now
2 days ago · Axsome Therapeutics, Inc. Total 3Q 2024 net product revenue of $104.8 million, representing 81% year-over-year growth. Auvelity® 3Q 2024 net product sales of $80.4 …
yahoo.com
OFF
Axsome Delivers Strong Q3 Revenue Beat | The Motley Fool
2 weeks from now
2 days ago · Axsome reported considerable year-over-year revenue growth in Q3, driven by its mainstay medications, Auvelity and Sunosi. Auvelity generated $80.4 million in net sales, an …
fool.com
OFF
Axsome Therapeutics Reports Third Quarter 2024 Financial Results …
2 weeks from now
3 days ago · Approximately 47,000 prescriptions were written for Sunosi in the U.S. in the third quarter of 2024, representing an increase of 15% compared to the same period in 2023, and …
financialpost.com
OFF
Neurology-Focused Axsome Therapeutics Reports Deeper Than
2 weeks from now
Feb 20, 2024 · Axsome Therapeutics Q4 2023 revenues surge to $71.53 million, Auvelity sales hit $130.1 million for the year. ... Sunosi (sleep disorder) net product revenues were $22.5 million …
benzinga.com
OFF
Will Auvelity & Sunosi Fuel Axsome's Growth Amid Stiff ... - Nasdaq
2 weeks from now
Oct 11, 2024 · In the first half of 2024, Sunosi’s net product sales were $42.2 million, reflecting an increase of almost 35.2% year over year. Sunosi has become an important revenue driver for …
nasdaq.com
OFF
Will Auvelity & Sunosi Fuel Axsome's Growth Amid Stiff …
2 weeks from now
Oct 11, 2024 · In the first half of 2024, Sunosi’s net product sales were $42.2 million, reflecting an increase of almost 35.2% year over year. Sunosi has become an important revenue driver for …
zacks.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
